medigraphic.com
Boletín Médico del Hospital Infantil de México

2012, Número 2

<< Anterior Siguiente >>

Bol Med Hosp Infant Mex 2012; 69 (2)


Direct medical costs of treating Mexican children under 2 years of age with respiratory syncytial virus

Mould-Quevedo JF, Contreras-Hernández I, Martínez-Valverde S, Villasís-Keever MA, Granados-García VM, Salinas-Escudero G, Muñoz-Hernández O

Idioma: Ingles.
Referencias bibliográficas: 23
Paginas: 111-115
Archivo PDF: 165.49 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Levy BT, Graber MA. Respiratory syncytial virus infection in infants and young children. J Fam Pract 1997;45:473-481.

  2. Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, et al. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr Infect Dis J 1999;18:223-231.

  3. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. The Tucson Children’s Respiratory Study. II. Lower respiratory tract illness in the first year of life. Am J Epidemiol 1989;129:1232-1246.

  4. Darville T, Yamauchi T. Respiratory syncytial virus. Pediatr Rev 1998;19:55-61. doi: 10.1542/pir.19-2-55.

  5. Dubois B, Ray G. Viral infections of the lower respiratory tract. In: Taussig LM, Landau LI, eds. Pediatric Respiratory Medicine: New York: Elsevier; 1999. pp. 573-579.

  6. Murtagh P, Cerqueiro C, Halac A, Avila M, Salomón H, Wissenbacher M. Acute lower respiratory infection in Argentinian children: a 40 month clinical and epidemiological study. Pediatr Pulmonol 1993;16:1-8.

  7. Miranda-Novales G, Solórzano-Santos F, Leaños-Miranda B, Vázquez-Rosales G, Palafox-Torres M, Guiscafre-Gallardo H. Blood culture and respiratory syncytial virus identification in acute lower respiratory tract infection. Indian J Pediatr 1999;66:831-836. doi:10.1007/BF02723847.

  8. Muraira GA, Villareal CE, Quiroga GA, Ábrego MV, Duran RAG, Cárdenas CBG, et al. Agentes virales en niños hospitalizados por infecciones respiratorias bajas. Rev Mex Pediatr 2002; 69;185-189.

  9. Noyola DE, Rodríguez-Moreno G, Sánchez-Alvarado J, Martínez-Wagner R, Ochoa-Zavala JR. Viral etiology of lower respiratory tract infections in hospitalized children in Mexico. Pediatr Infect Dis J 2004;23:118-123.

  10. World Health Organization. Acute respiratory infections (update September 2009). Respiratory syncytial virus and parainfluenza viruses. Available at: http://www.who.int/vaccine_research/diseases/ari/en/index2.html

  11. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143(suppl 5):S127-S132.

  12. Langley JM, Wang EE, Law BJ, Stephens D, Boucher FD, Dobson S, et al. Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr 1997;131:113-117.

  13. Ehlken B, Ihorst G, Lippert B, Rohwedder A, Petersen G, Schumacher M, et al. PRIDE Study Group. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr 2005;164:607-615.

  14. Banco Nacional de México. Tipo de cambio EUA. Tipo de cambio promedio Dólar/Euro 2005. Available at: http://www.banamex.com/esp/finanzas/historicos/economia_int/ei_eua_cambio.jsp?init=2005&offset=7

  15. Miedema CJ, Kors AW, Tjon A Ten WE, Kimpen JL. Medical consumption and socioeconomic effects of infection with respiratory syncytial virus in The Netherlands. Pediatr Infect Dis J 2001;20:160-163.

  16. Díez Domingo J, Ridao López M, Úbeda Sansano I, Ballester Sanz A. [Incidence and cost of hospitalizations for bronchiolitis and respiratory syncytial virus infections in the Autonomous Community of Valencia in Spain (2001 and 2002)]. An Pediatr (Barc) 2006;65:325-330.

  17. Stewart DL, Romero JR, Buysman EK, Fernandes AW, Mahadevia PJ. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention. Curr Med Res Opin 2009;25:2795-2804.

  18. Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006;118:2418-2423.

  19. Secretaría de Gobernación. Anexo Estadístico Tercer Informe de Gobierno, Felipe Calderón Hinojosa. Estadísticas Nacionales. México; 2009. pp. 251-270.

  20. Diario Oficial de la Federación. Instituto Mexicano Seguro Social. Costos Unitarios de Atención Médica. May 18, 2010. Available at: http://dof.gob.mx/nota_detalle.php?codigo=5143097&fecha=18/05/2010

  21. Instituto Mexicano del Seguro Social. Portal de Transparencia México. IMSS va a comprar. IMSS compró. January-December 2010. Available at: http://www.imss.gob.mx/transparencia/Pages/index.aspx.

  22. Glick HA, Doschi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. Handbooks in Health Economic Evaluation. Great Britain: Oxford University Press; 2007. pp. 89-113.

  23. Diario Oficial de la Federación. Banco de México. Tipo de cambio para solventar obligaciones denominadas en moneda extrajera pagaderas en la República Mexicana. March 24, 2011. Available at: http://www.notasfiscales.com.mx/indicadores.html




2020     |     www.medigraphic.com